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Abstract
Background: Plaque assays in cell culture monolayers under solid or semisolid overlay media are
commonly used for quantification of viruses and antiviral substances. To overcome the pitfalls of
known overlays, we tested suspensions of microcrystalline cellulose Avicel RC/CL™ as overlay
media in the plaque and plaque-inhibition assay of influenza viruses.
Results: Significantly larger plaques were formed under Avicel-containing media, as compared to
agar and methylcellulose (MC) overlay media. The plaque size increased with decreasing Avicel
concentration, but even very diluted Avicel overlays (0.3%) ensured formation of localized plaques.
Due to their low viscosity, Avicel overlays were easier to use than methylcellulose overlays,
especially in the 96-well culture plates. Furthermore, Avicel overlay could be applied without prior
removal of the virus inoculum thus facilitating the assay and reducing chances of cross-
contamination. Using neuraminidase inhibitor oseltamivir carboxylate, we demonstrated
applicability of the Avicel-based plaque reduction assay for testing of antiviral substances.
Conclusion:  Plaque assay under Avicel-containing overlay media is easier, faster and more
sensitive than assays under agar- and methylcellulose overlays. The assay can be readily performed
in a 96-well plate format and seems particularly suitable for high-throughput virus titrations,
serological studies and experiments on viral drug sensitivity. It may also facilitate work with highly
pathogenic agents performed under hampered conditions of bio-safety labs.
Background
Plaque assays in cell culture monolayers represent the
most common method for quantification of infectious
viruses and antiviral substances (see reference 1 for a
review). In these assays, each infectious virus particle mul-
tiplies under conditions that result in a localized area of
infected cells known as plaque. The plaques are revealed
either as area of dead/destroyed cells detected by general
cellular stains or as area of infected cells detected by
immuno-staining.
Some viruses, such as herpes viruses and poxviruses, may
be plaque-assayed under standard liquid culture medium,
because direct cell-to-cell spread of these viruses ensures
formation of localized plaques. However, many viruses,
including the influenza virus, do not form localized
plaques under liquid medium. This is because the prog-
eny of these viruses efficiently detach from infected cells
and spread over the cell monolayer with convectional
flow of the liquid medium, which results from the tem-
perature gradients in the culture vessels. In this case, large
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uneven foci of infected cells are formed, which cannot be
counted (for examples, see Fig. 4 and Fig. 6a). To prevent
liquid movement in the culture vessels and to control viral
spread, special overlay media are used. The most common
method is to solidify the culture medium with an agar (or
agarose) gel. The solid gel overlays, however, cannot be
used in 48- and 96-well culture plates required for auto-
mated high-throughput assays. As an alternative to solid
gels, viscous solutions of soluble hydrophilic polymers,
methylcellulose (MC), carboxymethylcellulose, traga-
canth gum, etc. can be employed [1].
We recently developed a focus reduction assay of influ-
enza virus sensitivity to neuraminidase inhibitors in 96-
well format under liquid medium [2]. Our efforts to per-
form this assay under MC overlays were discouraging due
to a high viscosity of methylcellulose-containing media.
As described below, we overcame this problem by
employing new overlay media based on suspensions of
microcrystalline cellulose Avicel™ RC/CL (FMC Biopoly-
mer). Avicel RC/CL is a colloidal form of water insoluble
cellulose microparticles blended with sodium car-
boxymethylcellulose to facilitate dispersion. Microparti-
cles of Avicel are readily dispersed in water to form
suspensions and thixotropic gels used in the preparation
of pharmaceutical suspensions and emulsions [3,4].
These properties of Avicel, as well as the relatively low vis-
cosity of Avicel-containing suspensions, prompted us to
test whether such suspensions can be used as a convenient
overlay media in the plaque assay of the influenza virus.
Results and discussion
Comparison of Avicel and agar overlays
We first compared Avicel-based overlay media with stand-
ard agar overlay in the plaque assay in 6-well plates. Fig. 1
illustrates results that were obtained in several replicate
experiments performed on different days. In all these
experiments, larger plaques were formed under Avicel-
containing overlays, as compared to standard agar over-
lay. The plaque size increased with decreasing Avicel con-
centration, but even diluted Avicel overlays ensured
formation of well-localized plaques. Somewhat more
plaques were formed under Avicel than under agar, pre-
Parallel plaque assays in 6-well plates under agar (left) and  1.2% Avicel RC-581 (right) Figure 2
Parallel plaque assays in 6-well plates under agar 
(left) and 1.2% Avicel RC-581 (right). Infection with A/
Memphis/14/96-M (H1N1) in MDCK cells. Replicate cultures 
were either immuno-stained with AEC (top) or stained with 
crystal violet dye (bottom).
Parallel plaque assays in 6-well plates under agar overlay and overlays containing 1.2%, 0.6%, and 0.3% of Avicel RC-581 Figure 1
Parallel plaque assays in 6-well plates under agar overlay and overlays containing 1.2%, 0.6%, and 0.3% of Avicel 
RC-581. MDCK cells were infected with influenza virus A/Memphis/14/96-M (H1N1) and immuno-stained using aminoethyl-
carbazole substrate (AEC).Virology Journal 2006, 3:63 http://www.virologyj.com/content/3/1/63
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sumably due to partial inactivation of the virus by heated
agar overlay.
Fig. 2 shows parallel assays under agar and Avicel overlays
with two commonly used methods of plaque detection,
immuno-staining and staining with crystal violet, to
reveal infected cells and destroyed cells, respectively. Avi-
cel overlay performed better than agar overlay irrespective
of the staining method.
FMC BioPolymer produces three different types of hydro-
phylic microcrystalline cellulose, Avicel CL-661, Avicel
RC-591 and Avicel RC-581 [3,4]. We compared them in
the same experiment using three different concentrations
for each type, 1.2% (Fig. 3), 0.6%, and 0.3% (data not
shown). The plaque size was independent of the Avicel
type, and the number of the plaques depended neither on
the Avicel type nor concentration. We arbitrarily used Avi-
cel RC-581 in all subsequent experiments.
Comparison of Avicel and methylcellulose overlays
Human influenza virus formed rather small plaques in
MDCK-SIAT1 cells under 1% methylcellulose overlay
(Fig. 4), in part due to inherently reduced virus spread in
this genetically modified cell line [2]. Lowering MC con-
centration to 0.5% resulted in only marginal increase in
the plaque size, whereas utilization of 0.25% MC resulted
in a formation of large comet-shaped foci. This peculiar
shape of foci suggested that the virus progeny is carried
over the cell monolayer by convectional movement of the
overlay medium [5] and that 0.25% MC overlay fails to
prevent such movement. By marked contrast, even the
most diluted Avicel-based overlay (0.3%) efficiently pre-
vented convectional flows in the culture medium while
still allowing relatively unrestricted radial growth of the
viral plaques. As a result, plaques formed under Avicel
were substantially bigger than those formed under MC.
The number of plaques did not differ between the two
types of overlays.
Importantly, suspensions of Avicel are much less viscous
than solutions of methylcellulose used in plaque assays
[1]. For example, 1.2% Avicel suspensions in water have
viscosity in the range of 100–200 mPa.s [3], whereas vis-
cosity of 2% MC solution in water is 3000–5000 mPa.s
[6]. Thus, even the most concentrated Avicel overlay
media tested in our experiments (1.2%) was still signifi-
cantly less viscous than the least concentrated MC
medium.
Plaque formation by different influenza virus strains
We tested eight human and avian influenza viruses
belonging to four HA and three NA antigenic subtypes for
the ability of these viruses to form plaques under Avicel
overlay (Fig. 5). All viruses, including highly pathogenic
avian H5N1 and H7N7 viruses, produced readily counta-
ble plaques. Thus, Avicel overlays appear suitable for
Parallel plaque assays under methylcellulose (top panel) and  Avicel RC-581 (bottom panel) Figure 4
Parallel plaque assays under methylcellulose (top 
panel) and Avicel RC-581 (bottom panel). Numbers 
depict concentrations of the MC and Avicel in the overlay. A/
Memphis/14/96-M (H1N1); MDCK-SIAT1 cells in 6-well 
plates; immuno-staining (AEC).
Parallel plaque assays under overlays prepared using three  different types of Avicel (CL-661, RC-591 and RC-581) with  the same concentration (1.2%) Figure 3
Parallel plaque assays under overlays prepared using 
three different types of Avicel (CL-661, RC-591 and 
RC-581) with the same concentration (1.2%). Infection 
with A/Memphis/14/96-M (H1N1) in MDCK cells. Two repli-
cate wells of the 6-well plate are shown for each overlay. 
Immuno-staining (AEC).Virology Journal 2006, 3:63 http://www.virologyj.com/content/3/1/63
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plaque assaying of a variety of influenza virus strains irre-
spective of their antigenic subtype and host species.
Plaque assays under Avicel in 96-well plates
Avicel overlays were readily compatible with the 96-well
microplate format. Due to their low viscosity, suspensions
of Avicel could be easily dispensed to and removed from
the plate wells by using the standard equipment for han-
dling liquid culture media (pipettes, dispensers, multi-
well washer manifolds, etc).
Plaque assays under agar and methylcellulose require
removal of the initial viral inoculum before addition of
the overlay [1]. The low viscosity of Avicel overlays
allowed us to skip this procedure making the assay easier
to perform and reducing chances of cross-contamination
during removal of the inoculums. In the experiment illus-
trated in Fig. 6, we infected MDCK-SIAT1 cells in a 96-well
plate with serial virus dilutions in the standard mainte-
nance medium. One hour later, we either removed virus
inoculum before adding the Avicel overlay medium (Fig.
6b, replicate rows 5–8), or added the same Avicel medium
without removing the virus suspension from the wells
(Fig. 6c, rows 9–12). Four replicate rows overlaid with the
liquid medium served to illustrate a lack of plaque locali-
zation without the addition of Avicel (Fig. 6a). As can be
seen, the simplified assay (c) was at least as sensitive as the
standard assay (b), and both assays had similarly low
well-to-well variation.
Assay of virus sensitivity to antiviral drugs
Fig. 7 demonstrates the applicability of the simplified Avi-
cel-based assay for testing of antiviral substances. One
hour after infecting replicate MDCK-SIAT1 cultures in
either 6-well or 96-well plate with the virus mixtures with
variable amounts of neuraminidase inhibitor oseltamivir
carboxylate, we added 1.2% Avicel overlay medium and
incubated cultures for 3 days (a) and 24 hr (b), respec-
tively. The results of the assays in 6-well plate and 96-well
plate closely agreed with each other and were consistent
with our previous data on sensitivity of this virus to osel-
tamivir carboxylate determined in the focus reduction
Plaques formed by influenza viruses in MDCK cells under 1.2% Avicel RC-581 overlay Figure 5
Plaques formed by influenza viruses in MDCK cells under 1.2% Avicel RC-581 overlay. Top row, from left to right: 
viruses isolated from humans A/Memphis/14/96-M (H1N1), A/Hong Kong/1/68 (H3N2), A/Hessen/1/03 (H3N2) and A/Thai-
land/KAN-1/04 (H5N1). Bottom row, from left to right: avian viruses A/Duck/Alberta/119/98, A/Duck/Minnesota/1525/81 
(H5N1), A/Chicken/Indonesia/1/05 (H5N1) and A/Chicken/Germany/R28/03 (H7N7). Immuno-staining with either True Blue 
(blue) or AEC (red).Virology Journal 2006, 3:63 http://www.virologyj.com/content/3/1/63
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assay [2]. In either case, the plaque size was reduced about
tenfold at 0.01 µM concentration of the drug, with some
reduction seen already at 0.001 µM concentration.
Conclusion
The plaque assays under microcrystalline cellulose over-
lays offer several advantages over assays that utilize solid
agar or semisolid MC media. Low overlay viscosity makes
the assay less cumbersome, especially in a microplate for-
mat. Bigger plaque size increases sensitivity and/or
reduces incubation time. Due to these advantages, Avicel-
based assays appear particularly suitable for high-
throughput virus titrations, serological studies and exper-
iments on viral drug sensitivity. Although tested here with
influenza virus, the assay will likely be applicable to many
other viral infections, and it may substantially facilitate
studies on highly pathogenic agents performed under
hampered experimental conditions of bio-safety labs.
Methods
Virus and cells
Unless indicated otherwise, all experiments were per-
formed using a clinical influenza virus isolate in MDCK
cells A/Memphis/14/96-M (H1N1) kindly provided by
Dr. Robert Webster (St. Jude Children's Hospital, USA)
[2]. The viruses described in Fig. 5 were kindly provided
by the colleagues listed in the Acknowledgements.
MDCK cells and MDCK-SIAT1 cells stably transfected with
2,6-sialyltransferase for enhanced expression of Neu5Ac2-
6Gal-terminated oligosaccharides were described previ-
ously [2]. We propagated both types of cells in DMEM
(Gibco) supplemented with 2 mM L-glutamine, 10% fetal
calf serum and antibiotics (streptomycin, 100 mg/ml and
penicillin, 100 U/ml).
Overlay media
As the liquid maintenance medium (MM) for virus infec-
tion, we used Eagle's MEM containing L-glutamine, 0.1%
BSA (Sigma, A-0336), antibiotics and 1 µg/ml TPCK
trypsin (Sigma, T-1426).
Stocks of 1.8 % Bacto-Agar (BD, 214010) and 2% methyl-
cellulose (Methocel MC, 3000–5500 mPa.s at 2%, Fluka)
in distilled water were prepared as described previously
[1].
The manufacturer of Avicel RC/CL (FMC BioPolymer)
kindly provided three types of Avicel (RC-581, RC-591
and CL-661) for testing. We prepared stock suspensions of
Avicel by dispersing 2.4 g Avicel powder in 100 ml dis-
tilled water on a standard magnetic stirrer for 1 hr. Agar,
MC and Avicel stocks were sterilized by autoclaving for 20
min at 121°C and stored at room temperature.
The overlays were prepared by mixing stock solutions of
MC, Avicel or melted agar with equal volumes of double-
strength maintenance medium. To vary the concentration
of MC and Avicel in the overlays, we diluted original
stocks with sterile water. The agar overlay was prepared at
42–44°C, two other overlays were prepared at either 20 or
37°C.
Concentrated (2.4%) Avicel stocks typically did not sepa-
rate during storage, diluted Avicel-based overlays, how-
ever, were less stable. If deemed necessary, we mixed
Three different assay variants (a-c) in 96-well plate Figure 6
Three different assay variants (a-c) in 96-well plate. 
Either 12 or 24 replicate wells with MDCK cells were inocu-
lated with tenfold dilutions of A/Memphis/14/96-M (H1N1) 
as depicted at the bottom of the figure. After 1 h of incuba-
tion, the viral inoculums were removed from the top eight 
rows of the wells; the inoculums were left intact in rows 9–
12. After that, standard liquid maintenance medium was 
added to rows 1–4; 1.2% Avicel RC-581 overlay medium was 
added to rows 5–12. TPCK-trypsin was included in each 
overlay medium to produce the final concentration of 1 µg/
ml. Immuno-staining 24 h post infection using True Blue sub-
strate.Virology Journal 2006, 3:63 http://www.virologyj.com/content/3/1/63
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Avicel stocks, and always mixed Avicel overlays before use
by either shaking with hand or vortexing. Slow separation
of overlays after their application on cell monolayers did
not affect the assay results.
Plaque assay in 6-well plates
One hour after infecting the cell monolayers with 30–50
plaque forming units of the virus in 1 ml of maintenance
medium without trypsin, we removed the virus inoculum,
covered the cells with 3 ml of the different overlay media
and incubated cultures at 35°C in 5% CO2 atmosphere. In
the case of MC and Avicel overlays, care was taken not to
disturb the plates during the incubation period in order to
avoid formation of non-even plaques. After three days of
incubation, we removed the overlays and fixed the cells.
Agar overlay was removed using metal spatula; MC, Avi-
cel, and liquid overlays were removed by suction. The cells
were fixed with 4% paraformaldehyde solution in MEM
for 30 min at 4°C and washed with PBS. All subsequent
treatments of the cells were performed at room tempera-
ture. We permeabilized the cells and simultaneously
blocked residual aldehyde groups by incubating the cells
for 10–20 min with 1 ml/well of solution containing 0.5
% Triton-X-100 and 20 mM glycine in PBS. We immuno-
stained virus-infected cells by incubating for 1 hr with
monoclonal antibodies specific for the influenza A virus
nucleoprotein (kindly provided by Dr. Alexander Klimov
at Centers for Disease Control, USA) followed by 1 hr
incubation with peroxidase-labeled anti-mouse antibod-
ies (DAKO, Denmark) and 30 min incubation with pre-
cipitate-forming peroxidase substrates. Solution of 10%
normal horse serum and 0.05% Tween-80 in PBS was
used for the preparation of working dilutions of immuno-
reagents. We washed the cells after the primary and sec-
ondary antibodies by incubating them three times for 3–
5 min with 0.05% Tween-80 in PBS. As peroxidase sub-
strates, we employed either ready to use True Blue™ (KPL)
or solution of aminoethylcarbazole (AEC, Sigma) (0.4
mg/ml) prepared in 0.05 M sodium acetate buffer, pH 5.5
and containing 0.03% H2O2. Stained plates were washed
with tap water to stop the reaction and dried. In the case
of True Blue staining, which is relatively unstable in water
solutions, plates were dried inverted in order to minimize
bleaching. Stained plates were scanned on a flat bed scan-
ner and the data were acquired by Adobe Photoshop 7.0
software.
As an alternative to immuno-staining, in some experi-
ments we revealed plaques as areas of destroyed cells. To
this end, after removing the overlays, we stained the cells
with 1% crystal violet solution in 20% methanol in water.
Variants of virus titration in 96-well plates
1. Standard variant
We infected MDCK or MDCK-SIAT1 cell monolayers in
96-well plates with 50 µl/well of serial dilutions of the
virus in the maintenance medium without trypsin. After 1
h incubation at 35°C in 5% CO2, we removed the virus,
added 100 µl/well of either MC or Avicel overlay media,
and incubated the cells for further 24 h to allow plaque
formation. Fixation and immuno-staining were per-
formed as described above for 6-well plates but using 50
µl of reagents per well.
2. Simplified variant
The assay was performed exactly as in the standard variant
with the following modifications. After 1 h incubation
with the virus, we did not remove the inoculum. We
added 100 µl/well of Avicel overlay media and mixed the
plate either by tapping with hand or using a plate mixer.
The media included increased amounts of trypsin (1.5 µg/
ml) to compensate for the dilution of the overlay with the
virus-containing material present in the wells.
Plaque reduction assay in MDCK-SIAT1 cells under Avicel  overlay Figure 7
Plaque reduction assay in MDCK-SIAT1 cells under 
Avicel overlay. A/Memphis/14/96-M (H1N1) was assayed 
for its sensitivity to the neuraminidase inhibitor oseltamivir 
carboxylate in 6 well plate (a) and in 96-well plate (b; 3 repli-
cate rows are shown in the figure) as described in the Meth-
ods section. Numbers depict final concentration of the 
inhibitor (µM) after the addition of the overlay.Publish with BioMed Central    and   every 
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Plaque inhibition assay
Noel Roberts (Roche Products, UK) kindly provided the
neuraminidase inhibitor oseltamivir carboxylate (OC).
We added 50 µl/well of serial 10-fold dilutions of OC in
maintenance medium without trypsin (concentration
range from 4 nM to 400 µM OC) to monolayers of
MDCK-SIAT1 cells in 96-well plates. We then added 50 µl/
well of virus dilutions (20–40 plaque forming units per
well). We mixed the plate and incubated it for 1 h at 35°C
to allow the initiation of viral infection. After that, we
added 100 µl/well of 1.2% Avicel overlay media contain-
ing 2 µg/ml trypsin, incubated cultures for 24 h and fixed
and immuno-stained them as described above.
In the case of 6-well plates, we added 0.75 ml aliquots of
the drug and the inhibitor and 1.5 ml aliquot of Avicel per
well and immuno-stained the plaques 3 days after infec-
tion.
Abbreviations
AEC, aminoethylcarbazole; MC, methylcellulose; MM,
maintenance medium; OC, oseltamivir carboxylate.
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